News

SBM Offshore Updates Share Repurchase Program Progress

SBM Offshore Updates Share Repurchase Program Progress

SBM Offshore Share Repurchase Program Overview

SBM Offshore has recently provided an update on its share repurchase program, revealing significant progress over the recent period ending early December. As part of a strategic initiative, the company has allocated a total of EUR130 million (approximately US$140 million) to this program, which was broken down into two parts—a EUR65 million initiative announced earlier in the year, further supplemented by an additional EUR65 million announced later on.

Objectives of the Share Repurchase Program

The primary goal of this share repurchase effort is twofold. Firstly, it aims to reduce the company’s share capital, which can enhance shareholder value. Secondly, it serves to provide shares necessary for various management and employee share schemes, thus supporting the internal equity framework.

Current Status and Summary of Transactions

From March to early December, SBM Offshore has successfully executed a substantial number of transactions under the programmed budget. As of December 4, 2024, the cumulative amount repurchased stands at EUR82,078,168, resulting in a total of 5,307,262 shares to date. The cumulative average repurchase price during this timeframe is approximately EUR15.47, indicating an efficient use of capital under the constraints of market conditions.

Insights from Recent Trading Days

The report further outlines the transactions conducted over the last few trading days of November and early December. For instance, on November 28, 2024, approximately 33,681 shares were repurchased at EUR17.14 each. Continuing through the dates, a clear pattern of strategic acquisition has emerged, with total shares repurchased over these days reaching 180,131, as recorded by December 4, indicating the effectiveness of the program.

Company Profile

SBM Offshore stands as a leader in deepwater ocean infrastructure, playing a key role in the energy industry through the design, construction, installation, and operation of offshore floating facilities. Their dedication to cleaner and more efficient energy production aligns with global sustainability goals, empowering them to pioneer advancements within the blue economy. With a workforce exceeding 7,400 individuals worldwide, SBM Offshore is committed to providing innovative solutions while maintaining balance with environmental responsibilities.

Investor Relations and Future Engagements

SBM Offshore remains engaged with its stakeholders through transparent communication and structured financial reporting. To bolster investor relations, key upcoming events include the full-year 2024 earnings report scheduled for February 20, 2025, and the Annual General Meeting on April 9, 2025. Such events provide vital opportunities for shareholders and potential investors to remain informed about the company's performance and strategic moves.

Frequently Asked Questions

What is the purpose of SBM Offshore's share repurchase program?

The share repurchase program aims to reduce share capital and provide shares for management and employee share schemes.

How much has SBM Offshore allocated for the repurchase program?

SBM Offshore has allocated a total of EUR130 million (around US$140 million) for the share repurchase program.

What is the cumulative amount repurchased as of December 4, 2024?

The cumulative amount repurchased totals EUR82,078,168, equating to 5,307,262 shares.

What has been the average repurchase price during the program?

The cumulative average repurchase price stands at approximately EUR15.47.

When are SBM Offshore's upcoming financial events?

Upcoming events include the full-year earnings report on February 20, 2025, and the Annual General Meeting on April 9, 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 2

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 4

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Halozyme's Upcoming Investment Presentation at Healthcare Conference

Updated Category News Views 277

Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...

Continue Reading
Revitalizing Everyday Sound: viaim's Collaboration with Orchestra

Updated Category News Views 181

Transforming Everyday Listening through Technology In an exciting development for audio enthusiasts, viaim, an innovative AI audio brand, has joined forces with the prestigious China Philharmonic Orchestra. This dynamic collaboration has given birth to the "Philharmonic Signature Sound," an advanced acoustic system meticulously designed to replicate the immersive...

Continue Reading
Unlocking the Future of Payments: Early Access for Wirex Pay Users

Updated Category News Views 103

Wirex Pay Revolutionizes Crypto Payments with Early Access Wirex Pay, a groundbreaking decentralized payment network, is thrilled to announce its innovative crypto payment application is now available for early access to select users. This opportunity marks a significant step towards the next wave of digital transactions, integrating cryptocurrencies into everyday...

Continue Reading
Inspire Investing Introduces New Fund Names for Better Clarity

Updated Category News Views 172

Inspire Investing Reveals Name Changes for ETFs Inspire Investing, renowned as the largest provider of faith-based ETFs, has announced significant updates to the names of two of its exchange-traded funds. These changes, aimed at increasing clarity regarding the funds' investment strategies, reflect Inspire's commitment to aligning their product offerings with investor...

Continue Reading
BASF's Recent Challenges Impact Earnings and Cash Flow Performance

Updated Category News Views 105

BASF Faces Headwinds in Latest Earnings Report Shares of BASF SE (OTC: BASFY) decreased by 2% following the publication of its third-quarter results. The company struggled to meet expectations across various divisions despite evidence of resilience in specific areas. Financial Performance Analysis BASF reported an adjusted EBITDA of €1,622 million, which is a notable 3%...

Continue Reading